 |
|
Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
Yoo Jin Na, Eun Sang Yu, Dae Sik Kim, Dae-Hee Lee, Sang Cheul Oh, Chul Won Choi
Korean J Intern Med. 2021;36(Suppl 1):S196-S206. Published online 2020 Apr 3 DOI: https://doi.org/10.3904/kjim.2019.336
|
|
Citations to this article as recorded by
 Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages
Arzu Zeynep Karabay, Tulin Ozkan, Asli Koc, Yalda Hekmatshoar, A. Selen Gurkan-Alp, Asuman Sunguroglu
Toxicology in Vitro.2024; 95: 105754. CrossRef Research Progress on the Use of Metformin in Leukemia Treatment
Qian Wang, Xudong Wei
Current Treatment Options in Oncology.2024; 25(2): 220. CrossRef Nilotinib Exerts a Therapeutic Approach via JAK/STAT Pathway and Cytokine Network in Chronic Myeloid Leukemia Cells
Burçin TEZCANLI KAYMAZ, Tunzala YAVUZ, Besne ÇELİK, Leila SABOUR TAKANLOU, İlayda ALÇITEPE, Maryam SABOUR TAKANLOU, Çığır AVCI, Nur SELVİ GÜNEL, Nur SOYER, Fahri ŞAHİN, Güray SAYDAM
Ege Tıp Dergisi.2024; 63(1): 124. CrossRef Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
Yi Zhang, Fang Zhou, Jiaheng Guan, Lukun Zhou, Baoan Chen
Biomolecules.2023; 13(2): 250. CrossRef Repurposing Metformin in hematologic tumor: State of art
Min Hu, Yan Chen, Tao Ma, Li Jing
Current Problems in Cancer.2023; 47(4): 100972. CrossRef Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
Min Ji Jeon, Eun Sang Yu, Chul Won Choi, Dae Sik Kim
The Korean Journal of Internal Medicine.2023; 38(6): 893. CrossRef Mitochondrial oxidative phosphorylation is dispensable for survival of CD34+ chronic myeloid leukemia stem and progenitor cells
Jin-Song Yan, Meng-Ying Yang, Xue-Hong Zhang, Chen-Hui Luo, Cheng-Kan Du, Yue Jiang, Xuan-Jia Dong, Zhang-Man Wang, Li-Xue Yang, Yi-Dong Li, Li Xia, Ying Lu
Cell Death & Disease.2022;[Epub] CrossRef Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway
Doriana Verrelli, Luca Dallera, Massimo Stendardo, Silvia Monzani, Sebastiano Pasqualato, Marco Giorgio, Rani Pallavi
Nutrients.2022; 14(13): 2669. CrossRef
|